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Abstract
FluMist influenza A vaccine strains contain the PB1, PB2, PA, NP, M, and NS gene segments of ca A/AA/6/60, the master donor virus–A
strain. These gene segments impart the characteristic cold-adapted (ca), attenuated (att), and temperature-sensitive (ts) phenotypes to the
vaccine strains. A plasmid-based reverse genetics system was used to create a series of recombinant hybrids between the isogenic non-ts
wt A/Ann Arbor/6/60 and MDV-A strains to characterize the genetic basis of the ts phenotype, a critical, genetically stable, biological trait
that contributes to the attenuation and safety of FluMist vaccines. PB1, PB2, and NP derived from MDV-A each expressed determinants
of temperature sensitivity and the combination of all three gene segments was synergistic, resulting in expression of the characteristic
MDV-A ts phenotype. Site-directed mutagenesis analysis mapped the MDV-A ts phenotype to the following four major loci: PB11195
(K391E), PB11766 (E581G), PB2821 (N265S), and NP146 (D34G). In addition, PB12005 (A661T) also contributed to the ts phenotype. The
identification of multiple genetic loci that control the MDV-A ts phenotype provides a molecular basis for the observed genetic stability of
FluMist vaccines.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Influenza is an acute febrile respiratory disease that
causes significant annual morbidity and mortality world-
wide. In the U.S. alone, influenza is responsible for approx-
imately 48 million infections and 20,000 deaths each year
(Barnett, 1998; Simonsen et al., 1997). Influenza type A
virus infection occurs frequently, causing significant sea-
sonal epidemics (Wright and Webster, 2001). Protective
immunity to influenza virus in humans is mediated primar-
ily by antibody responses to the surface hemagglutinin (HA)
and neuraminidase (NA) glycoproteins. Current inactivated
influenza vaccines are intended to elicit a humoral immune
response to the HA and NA of three currently circulating
strains, two influenza A strains (H3N2 and H1N1) and one
influenza B strain.
FluMist is a live-attenuated vaccine that protects children
and adults from influenza illness (Belshe et al., 1998; Nichol
et al., 1999). FluMist vaccine strains contain HA and NA
gene segments derived from the currently circulating wild-
type strains along with six gene segments, PB1, PB2, PA,
NP, M, and NS, from a common master donor virus (MDV)
(Maassab, 1967). The MDV for influenza A strains of Flu-
Mist (MDV-A) was created by serial passage of the wt
A/Ann Arbor/6/60 (A/AA/6/60) strain in primary chicken
kidney tissue culture at successively lower temperatures
(Maassab, 1967). MDV-A replicates efficiently at 25°C
(cold-adapted, ca), but its growth is restricted at 38 and
39°C (temperature sensitive, ts). This virus does not repli-
cate in the lungs of infected ferrets (attenuated, att) and is
safe and attenuated in children and adults (Belshe et al.,
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1998; Boyce et al., 2000; Edwards et al., 1994; Nichol et al.,
1999). Reassortants carrying the six internal genes of
MDV-A and the two HA and NA gene segments of the wt
virus (6:2 reassortant) consistently maintain these three phe-
notypes (Maassab et al., 1982).
The ts phenotype of FluMist vaccine strains is well
established. This property of FluMist strains is expected to
contribute to the attenuation of the vaccine in humans by
restricting its replication in all but the coolest regions of the
respiratory tract. The stability of this property has been
demonstrated in animal models and clinical studies. In con-
trast to the ts phenotype of influenza strains created by
chemical mutagenesis, the ts property of MDV-A did not
revert following passage through infected hamsters or in
shed isolates from children (for a recent review, see Murphy
and Coelingh, 2002). Attempts to map the ts lesions of ca
A/AA/6/60 using classic gene reassortment techniques in-
dicated that both PB2 and PB1 contributed to the ts pheno-
type (Snyder et al., 1988). These studies were carried out,
however, using a heterologous wt strain such as A/Korea/
1/82 as the wt non-ts parent. The large number of nucleotide
differences between these two strains (MDV-A and A/Ko-
rea/1/82) may have confounded the data due to gene con-
stellation effects, resulting from mixing gene segments from
two diverse parental strains. A constellation effect clearly
confounded the interpretation of the role of the M gene
segment with respect to the att phenotype using the classical
reassortment approach (Subbarao et al., 1992). In this re-
port, specific recombinant viruses, derived from highly re-
lated strains within the A/AA/6/60 lineage, are created and
analyzed with respect to the ts phenotype. The isogenic
nature of the two parental strains enables the evaluation of
single nucleotide changes on the ts phenotype. The genetic
basis for the ts phenotype of MDV-A is mapped to specific
amino acid residues within PB1, PB2, and NP.
Results
Generation of recombinant MDV-A from plasmids
To evaluate the genetic basis of the ts phenotype of
MDV-A, a set of recombinant plasmids was constructed that
enabled the creation of specific, defined recombinant vi-
ruses derived from this strain. Viral RNA from MDV-A was
reverse transcribed and amplified by PCR and the eight
cDNAs corresponding to the viral gene segments were in-
serted between the pol I and Pol II promoters of pAD3000
(Hoffmann et al., 2000). The viral inserts of individual
clones corresponding to each gene segment were sequenced
and, when necessary, corrected to match the consensus
MDV-A sequence. Infectious virus was obtained from the
cocultured COS-7/MDCK cells transfected with the eight
plasmids (pMDV-PB2, pMDV-PB1, pMDV-PA, pMDV-
NP, pMDV-HA, pMDV-NA, pMDV-M, and pMDV-NS)
and designated rMDV-A. rMDV-A was amplified in
chicken embryonic eggs and was shown to exhibit the
characteristic ts phenotype of nonrecombinant, biological
derived MDV-A (Fig. 1A, Table 1). The genomic viral
RNA of rMDV-A was sequenced and shown to be identical
to the plasmid-cloned cDNAs as well as the biological
MDV-A consensus sequence. Neither MDV-A nor
rMDV-A formed distinct plaques at 39°C, although both
formed easily visualized plaques at 33°C (Fig. 1A). This
plasmid set generated a precise, genetically manipulable
system for MDV-A.
Generation of recombinant wt A/AA/6/60 from plasmids
To perform a systematic, detailed analysis of the genetic
basis of the ts phenotype of MDV-A, the sequence of a
highly related, non-ts virus was identified and characterized.
Although the immediate wt progenitor of MDV-A was not
available, the sequence of several closely related non-ts,
non-att wt A/AA/6/60 strains with 17-48 nt differences
from the ca A/AA/6/60 had been previously described (Her-
locher et al., 1996). An additional closely related isolate, wt
A/AA/6/60 E10SE2, was obtained and sequenced in its
entirety. A total of 19 nt differences exist between E10SE2
and MDV-A (Fig. 1A, Table 2). E10SE2 was shown to be
non-ts (Table 1) and non-att in ferrets (data not shown). To
generate a recombinant non-ts virus, the MDV-A plasmids
were altered by site-directed mutagenesis to incorporate 15
of the 19 differences representing 10 amino acids changes.
Four of the nucleotide positions, PB21182, PB21212, PB1123,
and NP1550, that differed between MDV-A and E10SE2
were not altered from the MDV-A sequence, since these
nucleotides were observed in other non-ts isolates of A/AA/
6/60 and, therefore, not expected to have a role in expres-
sion of the ts phenotype (Herlocher et al., 1996). The re-
combinant wt virus (rWt), encoding the 15 nucleotide
changes, was obtained from the cocultured COS-7/MDCK
cells transfected with a set of eight plasmids, pWt-PB2,
pWt-PB1, pWt-PA, pWt-NP, pWt-M, pWt-NS, pMDV-HA,
and pMDV-NA. Sequencing analysis indicated that rWt
contained the designed genetic changes and was non-ts at
39°C, identical to the biologically derived wt A/AA/6/60
(E10SE2, Fig. 1A, Table 1). These observations demon-
strated that the ts phenotype could be mapped to a subset of
these 15-nt changes distributed among the six internal
genes.
Contribution of the six internal gene segments to virus ts
phenotype
Having established a reverse genetics system to recover
recombinant viruses derived from ts and non-ts A/AA/6/60
strains, rMDV and rWt, respectively, the effect of each wt
gene segment on the MDV-A ts phenotype was assessed by
creating recombinant, single-gene reassortants (Table 1).
Introduction of wt PB2 into rMDV-A resulted in a virus that
was only non-ts at 38°C; however, it remained ts at 39°C.
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The reduction in virus titer at 38 and 39°C (relative to 33°C)
was 0.6 log10 and 2.7 log10, respectively, as measured by
plaque assay in MDCK cells. The reassortant containing the
wt PB1 gene segment was non-ts, with respect to its ability
to form plaques at both 38 and 39°C. The plaque size of this
recombinant, however, was influenced by increased temper-
ature and was significantly reduced at 39°C as compared to
rWt. Introduction of the wt NP gene segment into rMDV-A
resulted in a virus that was also non-ts at 38°C, but in
contrast to the wt PB2 recombinant, the virus containing the
wt NP gene segment did not form plaques at 39°C. Intro-
duction of wt PA, M, or NS gene segments independently
into rMDV-A did not alter the ts phenotype, indicating that
these three gene segments had minimal or no role in main-
tenance of this phenotype. These results indicated that PB1,
PB2, and NP likely contributed to the MDV-A ts phenotype
in the order of PB1  PB2  NP.
Because neither wt PB1, wt PB2, or wt NP expressed
individually on the MDV-A background could create a
plaque size and plaques size profile identical to non-ts
rWt, these gene segments were introduced into MDV-A in
various combinations. The combination of wt PB1 and wt
PB2 resulted in a virus that was non-ts at both 38 and 39°C
(Table 1). Although the plaque size at 39°C was larger than
that of either single gene reassortant, it was significantly
smaller than rWt (Fig. 1B). A ts phenotype similar to wt
PB1/PB2 was observed for the virus containing the combi-
nation of wt PB2 and wt NP. The triple combination of wt
PB1/PB2/NP in rMDV-A resulted in a virus that was similar
or identical to rWt in its plaquing efficiency and plaque size
at 39°C (Fig. 1B, Table 1). Therefore, whereas the wt PB2,
PB1, and NP gene segments only partially reverted the ts
phenotype when introduced individually, the combination
of all three wt gene segments was able to fully revert the ts
phenotype to a non-ts behavior identical to rWt.
To determine whether these three gene segments were
capable of importing the characteristic MDV-A ts pheno-
type to rWt, the six internal gene segments derived from
MDV-A were introduced into rWt individually or in com-
bination. Introduction of single PB1, PB2, or NP gene
segments into rWt resulted in a reduction of virus titer at
38°C and a greater reduction at 39°C; however, none of
these single gene reassortants was as restricted at high
temperature as rMDV-A (Fig. 2). The PA, M, and NS gene
Fig. 1. Plaque morphology of recombinant viruses derived from A/AA/6/60. (A) Comparison of plaque morphology of rMDV-A with biologically derived
MDV-A and rWt with wt A/AA/6/60 (E10SE2) at 33 and 39°C. (B) Plaque morphology of reassortants between rMDV-A and rWt at 39°C. Virus-infected
MDCK cells were incubated at the indicated temperature for 3 days and plaques were immunostained with a chicken anti-MDV-A polyclonal antibody and
photographed.
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segments derived from MDV-A did not influence the non-ts
phenotype of rWt. Consistent with the previous reassort-
ments, it was demonstrated that introduction of both
MDV-A PB1 and PB2 genes into rWt backbone greatly
increased virus ts phenotype at 38°C; however, complete
reversion of virus ts phenotype required addition of the NP
gene (Fig. 2). Thus, the combination PB1, PB2, and NP
gene segments derived from MDV-A were necessary to
confer the complete ts phenotype.
Mapping the genetic loci that determined MDV-A ts
phenotype
The specific differences between the PB1, PB2, and NP
gene segments of rWt and rMDV-A were addressed sys-
tematically to identify those changes that played a signifi-
cant role in the ts phenotype. The NP gene of rMDV-A
differed from rWt NP only at nt 146 (D34G, Table 2). The
PB2 gene of rMDV-A differed from rWt at three sites, but
only nt 821 resulted in an amino acid change (N265S, Table
2) and presumably represented the ts locus located in the
PB2 gene segment. The PB1 gene of MDV-A differed from
rWt PB1 at 5 nt positions, of which four were coding
changes (Table 1). Each of the wt amino acid residue sub-
Table 1
Replication of MDV/Wt reassortants at various temperatures
Virus Virus titer (log10 PFU/ml)
33°C 38°C 33°C/38°C 39°C 33°C/39°C
Controls
MDV-A 8.91 6.10 2.82 4.0a 4.91
rMDV-A 8.72 6.19 2.53 4.0 4.72
Wt (E10SE2) 8.86 8.87 0.01 8.87 0.01
rWt 9.02 9.07 0.05 8.96 0.06
Wt gene segments
Wt-PB2 8.46 7.87 0.59 5.80b 2.66
Wt-PB1 8.92 8.74 0.18 7.86b 1.06
Wt-NP 8.40 7.24 1.15 4.0 4.40
Wt-PA 8.57 6.10 2.48 4.0 4.57
Wt-M 8.80 6.68 2.12 4.0 4.80
Wt-NS 8.72 6.10 2.62 4.0 4.72
Wt-PB1/PB2 8.94 8.89 0.05 8.10b 0.85
Wt-PB1/PB2/NP 8.52 8.38 0.14 8.41 0.1
Wt nucleotide residues
PB11195A 8.06 6.68 1.38 4.0 4.06
PB11395G 8.72 5.88 2.85 4.0 4.72
PB11766A 8.07 6.70 1.37 4.0 4.07
PB12005G 8.76 6.31 2.45 4.0 4.76
PB11195A1766A 8.65 7.60 1.05 5.98b 2.68
PB11195A1395G1766A 8.84 8.13 0.71 6.38b 2.46
PB11195A1766A2005G 8.79 8.12 0.66 7.14b 1.64
PB2821A/NP146A 8.81 8.21 0.59 7.56b 1.25
PB11195A/PB2821A/NP146A 8.86 8.81 0.05 7.60b 1.26
PB11766A/PB2821A/NP146A 9.33 8.84 0.50 8.71b 0.62
PB11766A2005G/PB2821A/NP146A 8.30 8.22 0.08 8.11b 0.18
PB11766A1395G/PB2821A/NP146A 8.88 8.85 0.03 8.39b 0.49
PB11195A1766A/PB2821A/NP146A 8.45 8.48 0.06 8.10 0.35
a The underlines indicate that no plaques were detected at 104-fold dilution.
b Indicates reduction in plaque size compared to rWt.
Table 2
Sequence comparison of wt A/AA/6/60 strain E10SE2, rMDV-A, and
rWt
RNA
segment
Base (amino acid)
position
Wt
(E10SE2)
MDV-A rWT
PB2 141 A G A
821 (265) A (Asn) G(Ser) A
1182 A T T
1212 C T T
1933 T C T
PB1 123 A G G
1195 (391) A (Lys) G (Glu) A
1395 (457) G (Glu) T (Asp) G
1766 (581) A (Glu) G (Gly) A
2005 (661) G (Ala) A (Thr) G
2019 C T C
PA 20 T C T
1861 (613) A (Lys) G (Glu) A
2167/8 (715) TT (Leu) CC (Pro) TT
NP 146 (34) A (Asp) G (Gly) A
1550 5A 6A 6A
M 969 (M2–86) G (Ala) T (Ser) G
NS 483 (NS1–153) G (Ala) A (Thr) G
Note. Numbers in bold represent the differences between MDV-A and
rWt.
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stitutions was placed individually into the PB1 gene seg-
ment of rMDV-A to assess their role in the ts phenotype.
PB11395G (Glu-457) and PB12005G (Ala-661) did not affect
the MDV-A ts phenotype. PB11195A (Lys-391) and
PB11766A (Glu-581) each resulted in a slight reduction in the
ts phenotype at 38°C, but had no effect at 39°C (Table 1).
These data indicated that PB11195A and PB11766A were the
likely ts loci in the PB1 gene segment. However, combina-
tion of both PB11195A and PB11766A did not produce a ts
phenotype similar to wt PB1 (Table 1). Addition of
PB12005G but not PB11395A to PB11195A/1766A further de-
creased the virus ts phenotype at 39°C, demonstrating that
PB12005A also had a role in the expression of the ts pheno-
type specified by the PB1 segment of MDV-A.
PB1 single-site mutations were then introduced together
with PB2821A and NP146A into rMDV-A. PB2821A/NP146A and
rMDV-A reassortant was non-ts at 38°C and had a titer reduc-
tion of 1.25 log10 at 39°C but its plaque size was much reduced
compared to rWt (Table 1). Addition of either PB11195A or
PB11766A did not significantly change the phenotype of wt
PB2/NP recombinant. Only the combination of PB11195A and
PB11766A, together with PB2821A and NP146A, resulted in a
virus that had the same non-ts phenotype as wt PB1/PB2/NP
and rMDV-A reassortant (Fig. 1B, Table 1). Addition of
PB11395G or PB12005G to wt PB11766A/PB2821A/NP146A did not
convert the virus to a characteristic rWt non-ts phenotype
(Table 1). These data, therefore, demonstrated that four amino
acids distributed in the PB1, PB2, and NP genes could com-
pletely revert the MDV-A ts phenotype.
To determine whether the characteristic MDV-A ts pheno-
type could be reproduced by introducing the ts residues iden-
tified in the PB1, PB2, and NP gene segments of MDV-A into
rWt, PB11195G, PB11766G, PB2821G, NP146G, or together with
PB12005A were introduced into rWt virus and virus ts pheno-
type was assessed. Recombinant virus containing four or five
MDV-A residues all exhibited a reduction of virus titer greater
than 4.5 log10 at 39°C, which was very similar to that of
rMDV-A. Therefore, these data demonstrate that a minimum
of four amino acids located in PB1, PB2, and NP are required
to confer the ts phenotype of MDV-A.
Discussion
MDV-A (i.e., ca A/AA/6/60) contributes its PB1, PB2,
PA, NP, M, and NS gene segments to each live-attenuated
FluMist influenza A vaccine strain. Clinical studies in over
20,000 adults and children involving 12 separate 6:2 reas-
sortant strains have shown that these vaccines are attenu-
ated, safe, and efficacious (Belshe et al., 1998; Nichol et al.,
1999). The ca A/AA/6/60 strain was originally created by
serially passaging the parental wt A/AA/6/60 strain at lower
temperatures (Maassab, 1967). During this process, ca
A/AA/6/60 acquired a characteristic set of biological traits,
including ts, ca, and att. The specific genetic components
and heritable biological traits of MDV-A that result in
appropriately attenuated vaccine strains are complex; none
of these phenotypes alone is solely responsible for creating
a safe vaccine. The ts phenotype of MDV-A, however,
certainly restricts the replication of vaccine viruses to the
cooler regions of the upper respiratory tract and, therefore,
contributes to the overall attenuation and safety of these
vaccines (Richman and Murphy, 1979). Genetic stability of
a critical biological trait that contributes to the safety of a
potential vaccine, such as the ts phenotype for live influenza
vaccines, is a prerequisite for a successful, safe vaccine.
Previous attempts to map the genetic basis of the ts
phenotype of ca A/AA/6/60 utilized classical coinfection
and reassortant techniques to create single and multiple
gene reassortants between ca A/AA/6/60 and an unrelated
wt strain. The seminal report of this approach mapped the ts
phenotype to the PB1 and PB2 segments of A/AA/6/60, and
the PB2 gene segment appeared to contain stronger ts de-
terminants (i.e., lower shut-off temperature and more re-
stricted replication at high temperature) than the PB1 gene
segment (Snyder et al., 1988). Interpretation of these stud-
ies, however, was confounded by constellation effects,
which were caused by mixing gene segments from two
rather divergent influenza A strains. Weakened interactions
could have occurred through changes between the ca A/AA/
6/60 and wt gene segments other than those specifically
involved in expression of the ts phenotype from the ca
A/AA/6/60 background. Constellation effects were shown
to confound the interpretation of association of the M gene
segment with the att phenotype (Subbarao et al., 1992).
Using a recently described reverse genetics system, we
identified the genetic basis of the ts phenotype within the
context of the ca and wt A/AA/6/60 genetic background by
comparing reassortants of the two recombinant isogenic
strains. The creation of a non-ts, non-att A/AA/6/60 recom-
binant strain that differed from MDV-A by only 15 nucle-
Fig. 2. Temperature sensitivity of rMDV-A and rWt reassortants. Each
reassortant containing the indicated MDV-A gene segment(s) in the rWt
background was titrated by plaque assay at 33, 38, and 39°C and the titer
reduction at 38 or 39°C verses 33°C was compared to rWt and rMDV-A.
The line represents the shut-off temperature (ts) of 2.0 log10.
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otides eliminated the problem of constellation effects con-
founding the interpretation of the phenotypes. Our results
confirmed the original observation that PB1 and PB2 con-
tributed to the expression of the ts phenotype (Snyder et al.,
1988); however, in an isogenic context, PB1 contributed
somewhat more of the ts characteristics than PB2. In addi-
tion, our studies indicated a role of the NP gene segment in
the ts phenotype of MDV-A, although it did not contribute
as much restriction as the PB1 and PB2 gene segments. The
observation that NP expressed some ts characteristics was
not revealed in the original analysis of reassortants created
from two divergent strains. In those studies, the ts determi-
nants on the A/AA/6/60 NP gene segment may not have
been strong enough when inserted into the wt background.
The ts phenotype of ca A/AA/6/60 does not have any
apparent determinants on the PA, M, or NS gene segments.
Interestingly, the only apparent locus common to MDV-A
and another cold-adapted vaccine strain, A/Leningrad/
134/47 (Klimov et al., 1992), is M969 (M2-A86S) in the M
gene segment. This locus, however, is not implicated in the
ts phenotype of MDV-A.
The genetic basis of the ts phenotype of MDV-A was
extended beyond previous studies by systematically identi-
fying the specific amino acid differences both singly and in
combination. This study demonstrated the role of PB11195
(K391E), PB11766 (E581G), PB2821 (N265S), NP146
(D34G), and possibly PB12005 (A661T) in conferring the ts
phenotype. PB12005 (A661T) alone was not sufficient to
confer any ts phenotype, but was required to confer the
complete non-ts phenotype exerted by the wt PB1 gene
segment. The single amino acid change at PB2821 was the
only nucleotide position that had been previously reported
as a determinant in the ts phenotype of MDV-A (Subbarao
et al., 1992). Interestingly, all the ts mutations are A to G or
G to A changes, the hypermutation that has been reported
previously for RNA virus genomes (Cattaneo, 1994) and all,
except PB2821 (N265S) and PB12005 (A661T), resulted in
alteration of charged amino acids. Modification of the
charged residues usually has minimal effect on protein con-
formation and has been widely used as an effective method
to generate ts mutants for a number of viruses. It is not
unexpected that the ts loci of MDV-A map to the viral
polymerase proteins. These proteins interact with one an-
other during RNA transcription and replication and remain
associated in ribonucleoprotein complexes in the virion. It is
likely that these amino acid changes affect protein–protein
interactions at nonpermissive temperatures.
Studies in humans and animals of MDV-A have demon-
strated the genetic stability of influenza A vaccines derived
from MDV-A. It is not surprising, therefore, that not one of
these changes can individually revert the temperature sen-
sitivity profile of the resulting virus to that of the rWt virus.
These changes appear to act in concert with one another to
fully express the ts phenotype and may have formed depen-
dently during the original low-temperature adaptation of the
ca A/AA/6/60 strain. In contrast to chemical mutagenesis,
which does not enable coevolution of changes, the continual
pressure to select for a strain that replicated efficiently at
low temperature during the creation of ca A/AA/6/60 con-
strained changes on one of these protein subunits to interact
in a stable manner with other subunits; occasionally this
would select for changes on the second protein or second
portion of the same protein. This coevolution of changes
distributed among several different gene segments may ex-
plain the genetic stability of the ts phenotype observed for
MDV-A-derived vaccine strains. At permissive tempera-
tures, the PB1, PB2, and NP proteins were selected to
interact efficiently with each other and changes in one were
stabilized by changes in one or more of the others.
We have not yet excluded the possibility that other ele-
ments may also contribute to the ts phenotype of MDV-A.
It is possible to use this reverse genetics system to further
enhance desirable phenotypes by the design of additional
nucleotide changes in the preexisting loci or by additional
alterations of the new regions of the genome (Scholtissek
and Spring, 1982; Subbarao et al., 1995). The five amino
acid loci responsible for the ts phenotype play a significant
role in the attenuation and safety of FluMist vaccines de-
rived from MDV-A. Further studies are being performed to
evaluate the role of these changes in the attenuation pheno-
type in animal models to determine whether the ts and att
phenotypes are encoded by the same, different, or overlap-
ping sets of nucleotide differences.
Materials and methods
Construction of the eight influenza A/AA/6/60 virus
plasmids
MDV-A, ca A/AA/6/60, was obtained from Dr. H.F.
Maassab of the University of Michigan (Maassab, 1967). Viral
RNA of MDV-A was extracted using a QIAamp Viral RNA
Mini Kit (Qiagen, Valencia, CA). The eight viral cDNA seg-
ments of MDV-A were amplified by RT-PCR from the viral
RNA with gene segment specific primers containing either
BsmBI (for PB1, PA, NP, NA, M, and NS) or AarI (for HA
and PB2) restriction enzyme sites. Both AarI and BsmBI
cDNA fragments were cloned between the two BsmBI sites of
the pAD3000 vector. This vector is a modification of
pHW2000 (Hoffmann et al., 2000), constructed by replacing
the bovine growth hormone polyadenylation signal with the
SV40 late mRNA polyadenylation sequence. All eight plas-
mids were sequenced and any nucleotide changes introduced
during the cloning process were corrected to represent the
authentic consensus MDV-A sequence using a QuikChange
Mutagenesis Kit (Stratagene, La Jolla, CA).
Site-directed mutagenesis was performed to further modify
the six internal genes to produce a non-ts reassortant. A total of
15 nucleotide substitution mutations were introduced into the
six MDV-A plasmids to represent the recombinant wild-type
A/AA/6/60 genome (rWt), as listed in Table 2.
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Recovery of recombinant influenza viruses from plasmids
Madin–Darby canine kidney (MDCK) cells and COS-7
cells were maintained in MEM containing 10% FBS and
cocultured in six-well plates at a ratio of 1:1 the day prior to
transfection. A set of eight plasmids were transfected into
the cocultured COS-7/MDCK cells by lipid TransIT-LT1
reagent (Mirus, Madison, WI) as described previously
(Hoffmann et al., 2000). The recovered virus was then
passaged in MDCK cells once, followed by amplification in
the allantoic cavities of embryonic chicken eggs. Transfec-
tion and virus growth in MDCK and eggs were performed at
33°C, a temperature permissive for both ca and wt viruses
to minimize any temperature selection pressures. Virus ge-
notype was confirmed by sequence analysis of cDNA frag-
ments amplified from viral RNA.
Temperature sensitivity of recombinant viruses
Temperature sensitivity of the recombinant viruses was
determined by plaque assay on MDCK cells at 33, 38, and
39°C. MDCK cells in six-well plates were infected with 400
l of 10-fold serially diluted virus and adsorbed at room
temperature for 60 min. The inocula were removed and
replaced with 1 L15/MEM containing 1% agarose and 1
g/ml TPCK-trypsin. The infected cells were incubated at
33°C in a CO2 incubator or in water-tight containers con-
taining 5% CO2 submerged in circulating water baths main-
tained at 38 0.1 or 39 0.1°C (Parkin et al., 1996). After
3 days’ incubation, the monolayers were immunostained
using chicken anti-MDV polyclonal antibodies and the
plaques were enumerated. Plaque counts obtained at each of
the temperatures were compared to assess the ts phenotype
of each virus and each assay was performed a minimum of
three times. The shut-off temperature (ts) was defined as the
lowest temperature that had a titer reduction of 100-fold or
greater compared to 33°C.
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